WO2007020617A3 - Produit - Google Patents

Produit Download PDF

Info

Publication number
WO2007020617A3
WO2007020617A3 PCT/IE2006/000088 IE2006000088W WO2007020617A3 WO 2007020617 A3 WO2007020617 A3 WO 2007020617A3 IE 2006000088 W IE2006000088 W IE 2006000088W WO 2007020617 A3 WO2007020617 A3 WO 2007020617A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
pmp118
megaplasmid
lactobacillus salivarius
chromosomal
Prior art date
Application number
PCT/IE2006/000088
Other languages
English (en)
Other versions
WO2007020617A9 (fr
WO2007020617A2 (fr
Inventor
Paul W O'toole
Gerald F Fitzgerald
Original Assignee
Univ College Cork Nat Univ Ie
Paul W O'toole
Gerald F Fitzgerald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cork Nat Univ Ie, Paul W O'toole, Gerald F Fitzgerald filed Critical Univ College Cork Nat Univ Ie
Publication of WO2007020617A2 publication Critical patent/WO2007020617A2/fr
Publication of WO2007020617A9 publication Critical patent/WO2007020617A9/fr
Publication of WO2007020617A3 publication Critical patent/WO2007020617A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne un polynucléotide isolé comprenant une séquence d'acides nucléiques, représentée par le numéro d'identification SEQ ID No. 1, ou un variant ou un fragment de cette séquence. L'invention concerne également un polynucléotide isolé comprenant une séquence d'acides nucléiques, représentée par les numéros d'identification SEQ ID No 2 à SEQ ID No. 30, ou un variant ou un fragment de cette séquence.
PCT/IE2006/000088 2005-08-18 2006-08-18 Produit WO2007020617A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IE20050544 2005-08-18
IE2005/0544 2005-08-18
IE20050566 2005-08-26
IE2005/0566 2005-08-26
IE20050859 2005-12-22
IE2005/0859 2005-12-22

Publications (3)

Publication Number Publication Date
WO2007020617A2 WO2007020617A2 (fr) 2007-02-22
WO2007020617A9 WO2007020617A9 (fr) 2007-06-14
WO2007020617A3 true WO2007020617A3 (fr) 2007-08-02

Family

ID=37451520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE2006/000088 WO2007020617A2 (fr) 2005-08-18 2006-08-18 Produit

Country Status (1)

Country Link
WO (1) WO2007020617A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019169181A1 (fr) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions et méthodes de traitement du cancer à l'aide de lactobacillus salivarius

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLAESSON M J ET AL: "Multireplicon genome architecture of Lactobacillus salivarius", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 103, no. 17, April 2006 (2006-04-01), pages 6718 - 6723, XP002402646, ISSN: 0027-8424 *
FLYNN SARAH ET AL: "Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118", MICROBIOLOGY (READING), vol. 148, no. 4, April 2002 (2002-04-01), pages 973 - 984, XP002410387, ISSN: 1350-0872 *
UNIVERSITY COLLEGE CORK, MICROBIOLOGY, IRELAND, CORK: "Lactobacillus salivarius subsp. salivarius UCC118 plasmid pSF118-20, complete sequence", 17 December 2004 (2004-12-17), XP002410388, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=genome&cmd=Retrieve&dopt=Overview&list_uids=18106> *
UNIVERSITY COLLEGE CORK, MICROBIOLOGY, IRELAND, CORK: "Lactobacillus salivarius subsp. salivarius UCC118 plasmid pSF118-44, complete sequence", 17 December 2004 (2004-12-17), XP002410389, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=genome&cmd=Retrieve&dopt=Overview&list_uids=18107> *

Also Published As

Publication number Publication date
WO2007020617A9 (fr) 2007-06-14
WO2007020617A2 (fr) 2007-02-22

Similar Documents

Publication Publication Date Title
WO2006106316A3 (fr) Amorces polynucleotidiques
NZ595501A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
WO2007049275A3 (fr) Polypeptides isoles, polynucleotides codant pour ces derniers, plantes transgeniques exprimant ces derniers et methodes utilisant ces derniers
WO2007093409A3 (fr) Acides nucleiques se liant au mcp-i
WO2007005645A3 (fr) Materiaux et procedes pour la generation de transcriptions d&#39;acide nucleiques modifiee en 2&#39;
WO2008009437A3 (fr) Acides nucléiques de liaison à sdf-i
IN2012DN06694A (fr)
WO2005030926A3 (fr) Variants de glycoside hydrolases
WO2008146745A1 (fr) Nouveau gène de lysophosphatidate acyltransférase
WO2009038194A1 (fr) Microorganisme recombinant et procédé de production d&#39;acide poly-gamma-glutamique
WO2006032724A3 (fr) Nouvelles enzymes laccase et leurs utilisations
EP2562256A3 (fr) Acides nucléiques de liaison C5a
WO2002028891A3 (fr) Listeria innocua, genome et applications
WO1999057282A3 (fr) Toxines pesticides et sequences nucleotidiques codant pour ces toxines
WO2004085607A3 (fr) Bacteries lactiques texturantes
WO2008087224A3 (fr) Netrine 4 mutée, fragments de cette dernière et utilisations comme médicament
WO2008156026A1 (fr) Homologue de la glycérol-3-phosphate acyltransférase (gpat) et son utilisation
WO2002016617A3 (fr) Enzyme
WO2001077334A3 (fr) Genome de lactococcus lactis, polypeptides et utilisations
WO2007020617A3 (fr) Produit
WO2004078991A3 (fr) Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
WO2011042901A3 (fr) Polynucléotides de bactériophage de brucella et utilisations correspondantes
EP1431400A3 (fr) Procédé pour détecter des bactéries acido-résistantes utilisant d&#39;ARN ribosomique comme cible
WO2003070925A3 (fr) Identification de genes et de micro-organismes 3-ketosteroid 9-alfa-hydroxylase bloques dans l&#39;activite de 3-ketosteroid 9-alfa-hydroxylase
AU6727000A (en) Process for producing coenzyme q10

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06766093

Country of ref document: EP

Kind code of ref document: A2